West Pharmaceutical Services, Inc. (WST)

Market Cap	15.15B
Revenue (ttm)	2.90B
Net Income (ttm)	467.20M
Shares Out	71.85M
EPS (ttm)	6.37
PE Ratio	33.09
Forward PE	33.14
Dividend	$0.84 (0.40%)
Ex-Dividend Date	Jul 30, 2025

Volume	1,473,724
Open	222.69
Previous Close	221.59
Day's Range	206.80 - 222.69
52-Week Range	187.43 - 352.33
Beta	1.09
Analysts	Buy
Price Target	331.67 (+57.27%)
Earnings Date	Jul 24, 2025

About WST

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhanc...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1923
• Employees: 10,600
• Stock Exchange: NYSE
• Ticker Symbol: WST
• Website: https://www.westpharma.com

Financial Performance

In 2024, WST's revenue was $2.89 billion, a decrease of -1.92% compared to the previous year's $2.95 billion. Earnings were $492.70 million, a decrease of -16.97%.

Analyst Summary

According to 7 analysts, the average rating for WST stock is "Buy." The 12-month stock price target is $331.67, which is an increase of 57.27% from the latest price.

Price Target

$331.67

(57.27% upside)

Analyst Consensus: Buy